Lumateperone

So here, quetiapine, which is often used as an augmentation treatment for sleep, although it can still have cardiometabolic side effects, even at 50 milligrams, has about one in four patients having sedation or somnolence.

The second highest is Lumateperon, not one in four, but a little bit under one in five.

And then the other treatments are about 8% and placebo about 4%.

Wes, I think it's time for you to step in.